Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Dr. Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Dr. Atsuko Nakayama, Sakakibara Heart Institute, Japan

Dr. Atsuko Nakayama, M.D., Ph.D., is a renowned cardiologist and expert in cardiovascular medicine and rehabilitation at the Sakakibara Memorial Hospital in Japan. She serves as the Director of the Department of Cardiovascular Medicine, Head of the Cardiac Rehabilitation Unit, and Director of the Comprehensive Support Center for Heart Disease. Dr. Nakayama is a pioneer in integrating AI and telemedicine into cardiac care and rehabilitation, with a focus on personalized treatment plans and wearable technologies. She holds leadership roles in several professional organizations and contributes to national policies on cardiovascular disease as a member of Japan’s Ministry of Health, Labour, and Welfare.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Atsuko Nakayama’s academic journey began with a strong foundation in medicine, culminating in a Doctorate from the prestigious University of Tokyo in March 2012. Her passion for cardiovascular medicine was evident from early on, and her academic excellence set the stage for a career that would merge clinical practice with cutting-edge research. Her early studies laid the groundwork for her future focus on medical device development, telemedicine, and rehabilitation in the cardiovascular field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Nakayama currently holds multiple leadership roles at the Sakakibara Memorial Hospital, where she serves as the Director of the Department of Cardiovascular Medicine, Head of the Cardiac Rehabilitation Unit, and Director of the Comprehensive Support Center for Heart Disease. Her leadership extends beyond her hospital, as she has been appointed as the representative of the Heart Disease Work-Life Balance Support Network in December 2024. Additionally, since June 2024, Dr. Nakayama has been a member of the Cardiovascular Disease Control Promotion Council under Japan’s Ministry of Health, Labour, and Welfare.

Her professional endeavors reflect a commitment to both the clinical and policy aspects of cardiovascular health. She has been at the forefront of integrating new technologies and rehabilitation approaches into routine care, improving patient outcomes through innovation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Dr. Nakayama’s research has focused on advancing the integration of technology in cardiovascular medicine, particularly through the use of artificial intelligence (AI) and telemedicine. She is recognized for her work in developing AI-driven diagnostic tools, wearable technologies, and remote cardiac rehabilitation programs. Her research also spans exercise physiology, aortic aneurysms, hypertrophic cardiomyopathy, and healthcare quality assessment.

Her pioneering work has enabled the development of AI-assisted patient monitoring systems and personalized treatment plans, revolutionizing cardiac rehabilitation. Dr. Nakayama has been instrumental in incorporating AI and big data analytics into cardiovascular care, allowing for predictive and preventive interventions in heart disease.

🌍IMPACT AND INFLUENCE:

Dr. Nakayama’s contributions extend well beyond the hospital and laboratory. Through her leadership in various professional organizations, including serving as the chair of the JCS-JJC committee of the Japanese Circulation Society since 2022, she has influenced the direction of cardiovascular research and practice in Japan. Her role in national policy-making, including her position on the Cardiovascular Disease Control Promotion Council, allows her to shape public health initiatives and promote AI-powered healthcare solutions on a national scale.

Her influence has been recognized by prestigious awards, including the “STI for SDGs” Award from the Japan Science and Technology Agency in 2024, recognizing her groundbreaking work in remotecardiac rehabilitation

📚ACADEMIC CITATIONS:

Dr. Nakayama’s research has been widely cited in the fields of telemedicine, AI in healthcare, and cardiovascular rehabilitation. Her work has paved the way for numerous studies exploring the use of technology to improve patient outcomes. As a fellow of both the Japanese Circulation Society and the American Heart Association, her research continues to have a significant impact on the scientific community.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Nakayama’s legacy is one of innovation, leadership, and compassionate care. Her contributions to AI-driven healthcare, particularly in the field of cardiology, have set new standards in patient care and rehabilitation. As she continues her work in AI-assisted diagnostics and rehabilitation, her future contributions promise to further revolutionize cardiovascular medicine and improve the lives of millions of patients.

Her ongoing efforts to shape policies, integrate cutting-edge technologies into clinical practice, and advocate for better healthcare systems ensure that Dr. Nakayama’s impact will be felt for years to come, leaving a lasting legacy in the world of medicine.

🌟CONCLUSION:

Dr. Atsuko Nakayama is a trailblazer in the field of cardiovascular medicine, combining clinical expertise with groundbreaking research in AI and telemedicine. Her leadership at Sakakibara Memorial Hospital, coupled with her contributions to national health policies, has made a lasting impact on cardiac care and rehabilitation in Japan. Through her innovative use of technology, she continues to improve patient outcomes and shape the future of healthcare. Dr. Nakayama’s dedication to advancing both medicine and healthcare systems ensures that her work will inspire generations of clinicians and researchers.

TOP NOTABLE PUBLICATIONS:

A national survey of career development according to gender and subspecialties among cardiologists in Japan
Authors: M. Shimbo, A. Nakayama, N. Fukue, T. Taniguchi, Y. Kobayashi
Journal: PLoS ONE
Year: 2025

Predicting Heart Rate at the Anaerobic Threshold Using a Machine Learning Model Based on a Large-Scale Population Dataset
Authors: A. Nakayama, T. Iwata, H. Sakuma, K. Kashino, H. Tomoike
Journal: Journal of Clinical Medicine
Year: 2025

Impact of Long-Term Exercise-Based Cardiac Rehabilitation in Patients With Chronic Heart Failure ― A Systematic Review and Meta-Analysis
Authors: S. Yamamoto, M. Okamura, Y. Akashi, S. Makita, M. Isobe
Journal: Circulation Journal
Year: 2024
Citations: 2

Sex Differences in Cardiovascular Disease-Related Hospitalization and Mortality in Japan ― Analysis of Health Records From a Nationwide Claim-Based Database, the Japanese Registry of All Cardiac and Vascular Disease (JROAD)
Authors: S. Noma, K. Kato, T. Otsuka, K. Maemura, Y.T. Tsukada
Journal: Circulation Journal
Year: 2024

sungil im | Arrhythmia | Best Researcher Award

Posted on 27/01/202527/01/2025 by Pencis

Dr. sungil im | Arrhythmia | Best Researcher Award

Dr. sungil im, kosin university, South Korea

Dr. Sungil Im is an Associate Professor of Cardiology at Kosin University Gospel Hospital, South Korea. With a distinguished career spanning over two decades, he specializes in cardiac electrophysiology, atrial myopathy, and advanced ablation techniques for arrhythmias. Dr. Im’s global expertise includes serving as an international cooperation doctor under KOICA in Kazakhstan and contributing to leading institutions like Korea University Medical Center and Samsung Medical Center. A Fellow of the American College of Cardiology (FACC) and European Society of Cardiology (FESC), his impactful research and clinical trials continue to shape advancements in cardiology worldwide.

Author Profile

Orcid Profile

Google Scholar Profile

📚 EARLY ACADEMIC PURSUITS:

Dr. Sungil Im’s journey in medicine began with a strong foundation in internal medicine and cardiology. After obtaining his Korean Medical Doctor license in 2003, he pursued a rigorous residency at Gyeong Sang National University Hospital, specializing in general internal medicine and cardiology. His academic milestones were marked by a continuous quest for excellence, which paved the way for his clinical expertise in cardiac electrophysiology.

🩺 PROFESSIONAL ENDEAVORS:

Dr. Im’s professional journey is a testament to his dedication and versatility. From 2008 to 2011, he served as an international cooperation doctor under KOICA at the Korea-Kazakhstan Friendship Hospital. This experience underscored his global commitment to advancing healthcare. Upon returning to Korea, he held key positions such as Clinical Fellow and Assistant Professor at esteemed institutions, including the Korea University Medical Center and Samsung Medical Center. Currently, he is an Associate Professor at Kosin University Gospel Hospital, where he continues to contribute significantly to cardiology education and clinical practice.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ARRHYTHMIA:

Dr. Im’s research interests are deeply rooted in advanced cardiac electrophysiology. His groundbreaking studies focus on atrial myopathy, cryoablation techniques for atrial fibrillation, and ventricular tachycardia ablation. His investigations into arrhythmogenesis and inflammation in atrial fibrillation patients have opened new avenues for understanding cardiac diseases. Additionally, his work on the association between ventricular arrhythmias and stroke has provided critical insights into improving patient outcomes.

🌍 IMPACT AND INFLUENCE:

Dr. Im’s influence extends beyond academia and clinical practice. He is a Fellow of the American College of Cardiology (FACC) and the European Society of Cardiology (FESC), reflecting his global recognition. As a board member of various Korean cardiology societies, he plays a vital role in shaping policies and advancing the field. His participation in multicenter clinical trials has further reinforced his reputation as a pioneer in cardiology research.

📖 ACADEMIC CITES:

Dr. Im has authored and contributed to numerous peer-reviewed studies and clinical trials, particularly in the fields of hypertension, medication adherence, and electrophysiology. His scholarly work is widely cited and respected, showcasing his intellectual contributions to cardiology.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Sungil Im’s legacy is one of relentless pursuit of excellence and innovation. His dedication to advancing cardiac care, mentoring future cardiologists, and driving groundbreaking research continues to leave a lasting impact. Looking ahead, his work promises to further enhance our understanding of complex cardiac disorders and improve global healthcare standards.

🌟 CONCLUSION:

Dr. Sungil Im exemplifies the qualities of a world-class researcher and educator. With a career marked by global service, pioneering research, and academic leadership, he stands as a beacon of inspiration in the field of cardiology. His legacy will undoubtedly influence generations to come.

TOP NOTABLE PUBLICATIONS

Pulsed field ablation of left ventricular myocardium in a swine infarct model

Authors: SI Im, S Higuchi, A Lee, C Stillson, E Buck, B Morrow, K Schneider, …

Journal: Clinical Electrophysiology

Year: 2022

Predictors of adverse outcome in patients with frequent premature ventricular complexes: the ABC-VT risk score

Authors: A Voskoboinik, A Hadjis, C Alhede, SI Im, H Park, J Moss, GM Marcus, …

Journal: Heart Rhythm

Year: 2020

Identification of markers associated with development of stroke in “Clinically Low‐Risk” atrial fibrillation patients

Authors: SY Shin, SJ Han, JS Kim, SI Im, J Shim, J Ahn, EM Lee, YM Park, JH Kim, …

Journal: Journal of the American Heart Association

Year: 2019

Effect of epicardial pulsed field ablation directly on coronary arteries

Authors: S Higuchi, SI Im, C Stillson, ED Buck, S Jerrell, CW Schneider, M Speltz, …

Journal: Clinical Electrophysiology

Year: 2022

Gap junction remodeling by chronic pressure overload is related to the increased susceptibility to atrial fibrillation in rat heart

Authors: SY Shin, WM Jo, TJ Min, BK Kim, DH Song, SH Hyeon, JE Kwon, WS Lee, …

Journal: EP Europace

Year: 2015

Usefulness of neutrophil/lymphocyte ratio in predicting early recurrence after radiofrequency catheter ablation in patients with atrial fibrillation

Authors: SI Im, SY Shin, JO Na, YH Kim, CU Choi, SH Kim, JW Kim, EJ Kim, …

Journal: International Journal of Cardiology

Year: 2013

Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients

Authors: JY Park, SW Rha, KL Poddar, S Ramasamy, KY Chen, YJ Li, BG Choi, …

Journal: Journal of Cardiology

Year: 2012

Thyrotoxicosis with coronary spasm that required coronary artery bypass surgery

Authors: SM Lee, TS Jung, JR Hahm, SI Im, SK Kim, KJ Lee, JM Lee, SI Chung

Journal: Internal Medicine

Year: 2007

Risk factor algorithm used to predict frequent premature ventricular contraction-induced cardiomyopathy

Authors: KM Park, SI Im, SJ Park, JS Kim, YK On

Journal: International Journal of Cardiology

Year: 2017

Impact of periodontitis as representative of chronic inflammation on long-term clinical outcomes in patients with atrial fibrillation

Authors: SI Im, J Heo, BJ Kim, KI Cho, HS Kim, JH Heo, JY Hwang

Journal: Open Heart

Year: 2018

Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Posted on 23/01/202523/01/2025 by Pencis

Prof. Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Prof. Yuan-Biao Qiao, Shanxi University of Chinese Medicine, China

Prof. Yuan-Biao Qiao is a senior leader at the Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on Chronic Inflammation, Shanxi University of Chinese Medicine, China. He holds a BC degree from Taiyuan University of Science and Technology (1992), an MS from Wuhan University (2005), and a Ph.D. from Qingdao University of Science and Technology (2007). Prof. Qiao completed post-doctoral research at Zhejiang University (2008–2010). With over 20 published research articles and a Shanxi Scientific and Technical Award, his work focuses on innovative drug development and integrating traditional Chinese medicine with modern science.

Author Profile

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Yuan-Biao Qiao’s academic journey began with his BC degree from Taiyuan University of Science and Technology in 1992. He furthered his studies at Wuhan University, earning an MS degree in 2005, followed by a Ph.D. from Qingdao University of Science and Technology in 2007. These foundational years highlight his dedication to acquiring a robust academic foundation, enabling him to excel in the field of medicine and traditional Chinese pharmacology.

💼PROFESSIONAL ENDEAVORS:

Prof. Qiao undertook a post-doctoral research stint at Zhejiang University between 2008 and 2010. This critical period allowed him to deepen his expertise, focus on innovative methodologies, and establish a strong presence in the academic and professional communities. Currently, he serves as a senior leader at the Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on Chronic Inflammation, a role that underscores his leadership and research acumen.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR PHARMACOLOGY:

Prof. Qiao’s primary research revolves around the development of innovative drugs targeting chronic inflammation and serious diseases, bridging traditional Chinese medicine with modern therapeutic approaches. His publication record includes more than 20 research articles, showcasing his commitment to advancing medical knowledge and addressing pressing healthcare challenges.

🌟IMPACT AND INFLUENCE:

Prof. Qiao’s work has earned him the prestigious Shanxi Scientific and Technical Award, a testament to the significance of his contributions. His research not only advances theoretical understanding but also translates into practical solutions, making a tangible impact on the field of medicine and drug development.

📖ACADEMIC CITES AND COLLABORATIONS:

With a consistent record of publishing high-quality research articles, Prof. Qiao has garnered citations and recognition from peers in the scientific community. His collaborative efforts extend to multidisciplinary teams, reflecting his ability to integrate diverse perspectives and foster innovation in research.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Qiao’s ongoing dedication to his field ensures his legacy as a pioneer in integrating traditional Chinese medicine with modern scientific practices. His future endeavors are likely to focus on enhancing the efficacy of therapeutic interventions and contributing to the global recognition of traditional Chinese medicine in treating complex diseases.

🏆CONCLUSION:

Prof. Yuan-Biao Qiao’s extensive academic qualifications, professional expertise, impactful research, and leadership make him a standout candidate for recognition as a Best Researcher. His ability to bridge traditional and modern approaches to medicine exemplifies a legacy of innovation and excellence, ensuring his continued influence in shaping the future of healthcare and science.

TOP NOTABLE PUBLICATIONS

Nrf2/NRF1 signaling activation and crosstalk amplify mitochondrial biogenesis in the treatment of triptolide-induced cardiotoxicity using calycosin

Authors: Qi, X.-M., Zhang, W.-Z., Zuo, Y.-Q., Ren, J.-H., Li, Q.-S.

Journal: Cell Biology and Toxicology

Year: 2025

Herb pair of Huangqi-Danggui exerts anti-tumor immunity to breast cancer by upregulating PIK3R1

Authors: Liu, H.-X., Lian, L., Hou, L.-L., Wen, S.-Y., Li, Q.-S.

Journal: Animal Models and Experimental Medicine

Year: 2024

Methionine redox regulation of actin-interacting proteins primarily governs antioxidative signaling and response to the salvianolic acid B treatment in EA.hy926 cells

Authors: Wang, A.-C., Qi, X.-M., Li, Q.-F., Qiao, Y.-B., Li, Q.-S.

Journal: Toxicology and Applied Pharmacology

Year: 2024

Bidirectional crosstalk of the cAMP/ROS-dependent signaling pathways in inflammatory macrophage: An activation of formononetin

Authors: Zhang, L.-F., Zhang, X.-Y., Wang, A.-C., Qiao, Y.-B., Li, Q.-S.

Journal: Toxicology and Applied Pharmacology

Year: 2023

PGC-1α/NRF1-dependent cardiac mitochondrial biogenesis: A druggable pathway of calycosin against triptolide cardiotoxicity

Authors: Qi, X.-M., Qiao, Y.-B., Zhang, Y.-L., Wei, H.-Z., Li, Q.-S.

Journal: Food and Chemical Toxicology

Year: 2023

Improving endothelial cell junction integrity by diphenylmethanone derivatives at oxidative stress: A dual-action directly targeting caveolar caveolin-1

Authors: Zhang, Y.-L., Yuan, H.-X., Sun, J., Qiao, Y.-B., Li, Q.-S.

Journal: Toxicology and Applied Pharmacology

Year: 2022

GSK3β-dependent lysosome biogenesis: An effective pathway to mitigate renal fibrosis with LM49

Authors: Ren, J., Wei, H., Sun, J., Xiao, B., Li, Q.

Journal: Frontiers in Pharmacology

Year: 2022

The protective effects of Mai-Luo-Ning injection against LPS-induced acute lung injury via the TLR4/NF-κB signalling pathway

Authors: Miao, J., Shen, J., Yan, C., Qiao, Y., Li, Q.

Journal: Phytomedicine

Year: 2022

New taraxasterane-type triterpenes from Diaphragma juglandis Fructus

Authors: Tan, J.-Y., Cheng, Y.-G., Li, J.-L., Li, Q.-S., Wang, Y.-L.

Journal: Tetrahedron Letters

Year: 2022

The Chemical Constituents of Diaphragma Juglandis Fructus and Their Inhibitory Effect on α-Glucosidase Activity

Authors: Tan, J., Cheng, Y., Wang, S., Li, Q., Wang, Y.

Journal: Molecules

Year: 2022

Eliza Wong | Cardiac Nursing | Best Researcher Award

Posted on 22/01/202524/01/2025 by Pencis

Dr. Eliza Wong | Cardiac Nursing | Best Researcher Award

Dr. Eliza Wong, Tung Wah College, Hong Kong

Dr. Eliza Wong is an esteemed Associate Professor at Tung Wah College, Hong Kong, with extensive experience in nursing education, research, and clinical practice. She specializes in e-health interventions, acute care, and cardiovascular nursing, focusing on preventive care, gerontechnology, and lifestyle educational programs. Dr. Wong’s impactful research has garnered substantial funding, including Health and Medical Research Fund (HMRF) grants, and her work is widely published in leading international journals. A dedicated mentor and global collaborator, she actively advances nursing education and practice, shaping the next generation of healthcare professionals and contributing to improved patient outcomes worldwide.

Author Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

EDUCATION:

Dr. Wong Mi Ling, Eliza, possesses an impressive academic foundation in nursing and healthcare management. She earned her PhD in Nursing from The Chinese University of Hong Kong (2003–2009), focusing on improving patient care through evidence-based research. She also holds a Master of Nursing from Deakin University, Australia (1999–2001), and a Master of Health Administration from the University of New South Wales, Australia (1995–1997), which reflect her dual expertise in clinical practice and healthcare leadership. Additionally, she completed her Bachelor of Health Science in Nursing at the University of Western Sydney, Australia (1992–1993), establishing her strong clinical foundation.

PROFESSIONAL QUALIFICATION:

Dr. Wong Mi Ling, Eliza, boasts outstanding professional qualifications in nursing and healthcare. She is a Fellow of the Hong Kong College of Education and Research at the Hong Kong Academy of Nursing (HKAN) since 2012 . A committed member of Sigma (Pi Lota at-Large Chapter) , she has been a Registered General Nurse in Hong Kong since 1982 and a Registered Midwife since 1984 . Her international credentials include being a Registered Nurse in NSW, Australia (1990–2017). Additionally, she has certifications in International Trauma Life Support (2017–2021) and Basic Life Support (2017–2019) .

PROFESSIONAL EXPERIENCE:

Dr. Wong Mi Ling, Eliza, has an extensive professional journey in nursing and education. She serves as an Associate Professor at Tung Wah College (2021–present) and previously held roles at the Polytechnic University of Hong Kong as Principal Research Fellow (2020–2021) and Assistant Professor (2017–2020) . She has also contributed as a Nurse Educator at Hong Kong Sanatorium & Hospital (2016–2017) and Assistant Professor at CUHK (2010–2016) . Her diverse experience spans roles in nursing education, consultancy, and frontline care in Hong Kong and Australia, including A&E, obstetrics, and rehabilitation units .

RESEARCH INTERESTS ON CARDIAC NURSING:

Dr. Wong Mi Ling, Eliza, research interests encompass e-health interventions for conditions like coronary heart disease and metabolic syndrome, acute care with a focus on pain and emergency nursing, and cardiovascular nursing, including preventive care, rehabilitation, and lifestyle education. Their PhD research emphasized educational interventions in acute pain management for patients with limb fractures. With extensive experience in emergency nursing, their studies explore nurse-led wound care and triage pain management. Since 2017, they have focused on gerontechnology and health literacy for older adults, securing significant grants. Their prolific contributions include 46 international publications, numerous impactful conference papers, and active roles in collaborative research and peer review.

AWARDS AND HONORS:

Dr. Wong Mi Ling, Eliza has received numerous awards and honors throughout her distinguished career. Her accolades reflect her outstanding contributions to nursing education, research, and practice. Dr. Wong has been recognized for her impactful work in cardiovascular nursing and e-health interventions, securing prestigious research grants such as the Health and Medical Research Fund (HMRF) and Knowledge Transfer Fund. She serves as a member of the International Advisory Board for International Emergency Nursing and actively contributes as a peer reviewer for esteemed journals like BMJ Open Access and the Journal of Advanced Nursing. Her dedication continues to inspire excellence in nursing.

CITATIONS:

Citations – 2074
h-index – 26
i10-index – 58

CONCLUSION:

Dr. Wong Mi Ling, Eliza has established herself as a visionary leader in nursing, blending rich clinical experience with groundbreaking research and education. Her contributions to e-health interventions, acute care, and cardiovascular nursing have significantly advanced nursing practice and patient care. Through her commitment to mentorship, she has nurtured the next generation of healthcare professionals, fostering innovation and academic excellence. With a global reputation as a scholar, advisor, and educator, Dr. Wong continues to drive progress in nursing, ensuring her work has a lasting impact on healthcare systems and communities worldwide. Her dedication remains a beacon of inspiration and excellence.

TOP NOTABLE PUBLICATIONS

Title: The associations of e-health perception and dementia knowledge with dementia public stigma in nursing students: A cross-sectional study
Authors: Su, J.J., Tsui, K.Y., Lam, S.C., Suen, L.K.P., Kwan, R.Y.C.
Journal: Nurse Education Today
Year: 2025, 146, 106532

Title: Effect of a Nurse-Led Support Program Using Mobile Application Versus Nurse Phone Advice on Patients at Risk of Coronary Artery Disease: A Randomized Controlled Trial
Authors: Wong, E.M.L., Leung, D.Y.P., Lam, S.C., Ko, S.Y., Leung, A.Y.M.
Journal: Worldviews on Evidence-Based Nursing
Year: 2025, 22(1), e12765

Title: Lifestyle intervention using a mobile application versus booklet for adults with metabolic syndrome: a multicentre randomised controlled trial (abridged secondary publication)
Authors: Leung, D.Y.P., Wong, E.M.L., Leung, A.M.Y., Cheung, A.S.P., Cheung, K.C.
Journal: Hong Kong Medical Journal
Year: 2024, 30(6), pp. 12–16

Title: Coping strategies of internally displaced persons and the host community in a region of armed conflict: A cross-sectional study
Authors: Salihu, D., Chutiyami, M., Bello, U.M., Sulaiman, S.K., Kwan, R.Y.C.
Journal: Psychiatry Research
Year: 2024, 339, 116035

Title: Effectiveness of a home-based music-paced physical activity programme on exercise-related outcomes after cardiac rehabilitation: a randomized controlled trial
Authors: Chair, S.Y., Cheng, H.Y., Lo, S.W.S., Choi, K.C., Leung, T.S.Y.
Journal: European Journal of Cardiovascular Nursing
Year: 2024, 23(5), pp. 510–520

Title: Integrated Health Education Programmes With Physical Activity Among Community-Dwelling Older Adults at Risk of Atherosclerotic Cardiovascular Disease: An Integrative Review of Experimental Studies
Authors: Lo, F., Wong, E., Lam, K., Huang, X., Ho, K.
Journal: Journal of Advanced Nursing
Year: 2024

Title: Effects of virtual reality on anxiety and pain in adult patients undergoing wound-closure procedures: A pilot randomized controlled trial
Authors: Ko, S.Y., Wong, E.M.L., Ngan, T.L., Tam, H.F., Chan, C.C.
Journal: Digital Health
Year: 2024, 10

Title: Music-paced physical activity intervention for patients with coronary heart disease: abridged secondary publication
Authors: Chair, S.Y., Sit, J.W.H., Wong, E.M.L., Yu, D.S.F., Leung, T.S.Y.
Journal: Hong Kong Medical Journal
Year: 2024, 30(1), pp. 18–22

Title: Sensitivity and specificity of conventional and new face validation in determining the incomprehensible items by older people: Empirical evidence of testing 106 quality-of-life items
Authors: Lam, S.C., Suen, L.K.P., Huang, E.Y.-Z., Cheung, D.S.K., Kwan, R.Y.C.
Journal: Aging Medicine
Year: 2023, 6(3), pp. 230–238

Title: The effect of a lifestyle intervention program using a mobile application versus the effect of a program using a booklet for adults with metabolic syndrome: A three-arm randomized controlled trial
Authors: Wong, E.M.L., Leung, D.Y.P., Wang, Q., Leung, A.Y.M., Cheung, A.S.P.
Journal: Journal of Nursing Scholarship
Year: 2023, 55(5), pp. 936–948

Mincai li | vascular calcification | Best Researcher Award

Posted on 26/12/202426/12/2024 by Pencis

Prof. Dr. Mincai li | vascular calcification | Best Researcher Award

Prof. Dr. Mincai li, Hubei University of Science and Technology, China

Prof. Dr. Mincai Li is a distinguished academic at Hubei University of Science and Technology, China. He holds an MD and Master’s degree in Pathology and Pathophysiology from Huazhong University of Science and Technology. With extensive experience in teaching, Prof. Li has served as a Professor since 2017, after roles as Associate Professor and Lecturer at the same institution. His research focuses on the molecular mechanisms of atherosclerosis and the efficacy of glioma drugs. He has published over 40 scientific papers, including 15 SCI-indexed articles, and has received multiple awards for his scientific and teaching contributions.

Author Profile

Scopus Profile

🎓 Education Background:

Prof. Dr. Mincai Li completed his MD in Pathology and Pathophysiology at Huazhong University of Science and Technology (2007-2010), graduating in the top 10% of his class. He also earned his Master’s in Pathology and Pathophysiology from the same institution (2004-2007), ranking in the top 10%. Prior to that, he obtained a Bachelor’s in Clinical Medicine from Hubei University of Science and Technology (1993-1998), where he was in the top 30% of his cohort.

💼 Professional Experience:

Prof. Dr. Mincai Li has an extensive academic career at Hubei University of Science and Technology, where he has held progressively senior roles. Since January 2017, he has served as a Professor, following his tenure as Associate Professor from January 2012 to December 2016. From July 2010 to December 2011, he was a Lecturer, and earlier in his career, he worked as a Teaching Assistant from July 1998 to August 2004. Throughout his tenure, Prof. Dr. Li has contributed significantly to education and research in his field, shaping the academic environment at the university.

🩺 Medical Education & Teaching:

Prof. Dr. Mincai Li has made significant contributions to medical education, primarily teaching Pathology and Oral Histopathology courses. He has played a leading role in three provincial teaching research projects within Hubei’s higher education institutions, demonstrating his commitment to advancing academic standards. His exceptional teaching efforts have been recognized with awards, including a second prize and a third prize for teaching achievements at Hubei University of Science and Technology. Prof. Dr. Li’s dedication to both education and research has made a lasting impact on the academic community and the development of future medical professionals.

🔬 Scientific Research:

Prof. Dr. Mincai Li’s research primarily focuses on the molecular mechanisms of atherosclerosis and the efficacy of glioma drugs. He has led and contributed to 10 national, provincial, and municipal research projects, showcasing his expertise in these critical areas. Prof. Li has published over 40 scientific papers, including 15 SCI-indexed articles, and has edited a textbook. His significant contributions to scientific research have earned him recognition, including a second prize and a third prize for scientific and technological progress in Xianning City. His work continues to advance the understanding of critical medical conditions and therapeutic approaches.

🏅 Achievements and Honors:

Prof. Dr. Mincai Li has earned several prestigious awards throughout his career. In 2015, he was honored with the Second and Third Prizes for Science and Technology Progress in Xianning City, recognizing his contributions to scientific advancement. In 2016, he received both the Second and Third Prizes for Teaching Achievements at Hubei Institute of Science and Technology, highlighting his dedication to education. That same year, Prof. Li was awarded the Third Prize for the Second Natural Science Outstanding Academic Achievement Thesis Award in Xianning City, further acknowledging his impactful research and academic excellence. These accolades reflect his commitment to both teaching and scientific progress.

🌟Conclusion:

Prof. Dr. Mincai Li is a highly accomplished academic and researcher at Hubei University of Science and Technology, China. With a strong background in Pathology and Pathophysiology, he has made significant contributions to both education and scientific research. His work on atherosclerosis and glioma drugs has earned him national and regional recognition. As a dedicated professor, he has shaped the academic development of many students, while his research continues to advance medical science. Prof. Li’s numerous awards and honors reflect his unwavering commitment to excellence in both teaching and research.

Top Notable Publications:

Target analysis and identification of curcumin against vascular calcification

Authors: Li, Q., Zhou, Q., Li, S., Li, M., Xia, H.

Journal: Scientific Reports

Year: 2024

The causal relationship between thoracic aortic aneurysm and immune cells: a mendelian randomization study

Authors: Liu, G., Pan, S., Xia, H., Li, M., Wu, A.

Journal: BMC Cardiovascular Disorders

Year: 2024

Attenuating Atherosclerosis through Inhibition of the NF-κB/NLRP3/IL-1β Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs)

Authors: Li, S., Li, Q., Zhou, Q., Liu, C., Li, M.

Journal: Cardiovascular Therapeutics

Year: 2024

Identification of key genes and pathways in atherosclerosis using integrated bioinformatics analysis

Authors: Li, S., Li, Q., Zhou, Q., Liu, C., Li, M.

Journal: BMC Medical Genomics

Year: 2023

Bioinformatic Identification of the Pyroptosis-Related Transcription Factor-MicroRNA-Target Gene Regulatory Network in Angiotensin II-Induced Cardiac Remodeling and Validation of Key Components

Authors: Huang, T., Ding, J., Lin, L., Yu, L., Li, M.

Journal: Frontiers in Bioscience (Landmark edition)

Year: 2023

Increased Neuromedin B is Associated with a Favorable Prognosis in Glioblastoma

Authors: Li, S., Li, Q., Zhou, Q., Liu, C., Li, M.

Journal: Frontiers in Bioscience – Landmark

Year: 2023

Study on mechanism of resveratrol regulation of NLRP3 mediated pyroptosis of vascular smooth muscle cells resistance to atherosclerosis

Authors: Li, S., Li, Q., Zhou, C., Ouyang, C., Li, M.

Journal: Drug Evaluation Research

Year: 2022

Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression

Authors: Wang, Z., Liu, F., Liao, W., Li, M., Xia, H.

Journal: Archives of Biochemistry and Biophysics

Year: 2020

Captopril Attenuates the Upregulated Connexin 43 Expression in Artery Calcification

Authors: Li, M., Wang, Z., Shao, J., Yu, L., Hu, Z.

Journal: Archives of Medical Research

Year: 2020

Paweł Rajewski | Cardiovascular risk | Best Research Article Award | Best Research Article Award

Posted on 11/11/202411/11/2024 by Pencis

Prof Dr. Paweł Rajewski | Cardiovascular risk | Best Research Article Award

Prof Dr. Paweł Rajewski, WSOZ, Poland

🌟Bioinformatics:

Prof. Dr. Paweł Rajewski is a leading expert in internal medicine, infectious diseases, hepatology, and clinical transplantation. Serving as the Rector of the Faculty of Health Sciences at the University of Health Sciences in Bydgoszcz, Poland, he is also the Provincial Consultant in Infectious Diseases for the Kuyavian-Pomeranian Voivodeship. In addition, he heads both the Department of Internal Medicine and Infectious Diseases at Tadeusz Browicz Provincial Infectious Disease Hospital and the Liver, Internal, Infectious, and Metabolic Disorders Clinic at CM Gizińscy in Bydgoszcz. Dr. Rajewski is a certified lipidologist and obesitologist, with over 200 published articles focusing on metabolic disorders, liver diseases, and cardiovascular health. He is also the founder of the Dr. Rajewski Foundation, which supports research and education in health sciences.

Profile:

Orcid Profile

🏥Current Position and Roles:

Dr. Paweł Rajewski is a distinguished medical doctor, professor, and the rector of the Faculty of Health Sciences at the University of Health Sciences in Bydgoszcz. He holds the vital role of Provincial Consultant in Infectious Diseases for the Kuyavian-Pomeranian Voivodeship, providing oversight and strategic insights on infectious disease management in the region. Dr. Rajewski serves as the Head of the Department of Internal Medicine and Infectious Diseases at the Tadeusz Browicz Provincial Infectious Disease Hospital in Bydgoszcz, as well as the Head of the Liver, Internal, Infectious, and Metabolic Disorders Clinic at CM Gizińscy in Bydgoszcz. Previously, he served as the Medical Director and Head of the Department of Internal Medicine and Hepatology at the Emil Warmiński Multispecialist City Hospital. Through these roles, he contributes to the health of countless patients while also shaping medical policy and practice.

🎓Academic Background:

Dr. Rajewski’s academic journey has been marked by an enduring commitment to medicine, specializing in areas such as internal medicine, infectious diseases, hepatology, and clinical transplantation. His qualifications in these areas form the bedrock of his clinical and academic expertise, enabling him to deliver high-impact research and patient care in fields that are central to public health. Dr. Rajewski’s education includes specialty certifications as a lipidologist, accredited by the Polish Lipid Association, and an obesitologist with certifications from the Polish Association for the Study of Obesity and the Polish Society for Obesity Treatment.

📚Research Interests and Publication Achievements:

Dr. Rajewski has contributed over 200 articles, primarily focused on metabolic disorders, obesity, liver diseases, and cardiovascular risk factors. His work, published in reputed medical journals, has been instrumental in advancing knowledge on these critical health issues. His research sheds light on complex metabolic processes, influencing both preventive and therapeutic approaches to conditions like non-alcoholic fatty liver disease and atherosclerosis. His publications are widely recognized for their scientific rigor and relevance, contributing to his esteemed reputation in the medical research community.

🔬Ongoing Research Projects:

Dr. Rajewski is currently engaged in various research projects that address emerging concerns in metabolic health and infectious diseases. His work on liver disease mechanisms and cardiovascular risk factors associated with obesity and metabolic syndrome aims to uncover better diagnostic markers and treatment pathways. A recent focus involves studying COVID-19’s impact on liver function and the interplay between viral infections and metabolic health, topics highly relevant in today’s healthcare landscape.

👥Professional Associations and Certifications:

Dr. Rajewski’s memberships in prestigious medical associations, including the Polish Lipid Association and the Polish Association for the Study of Obesity, underscore his dedication to staying at the forefront of medical science. His certified expertise as a lipidologist and obesitologist enables him to approach health issues with a comprehensive understanding of lipid and metabolic disorders, enhancing the efficacy of treatments and preventive measures.

🏆Scholarships and Awards:

Dr. Rajewski’s contributions to medicine have earned him numerous accolades, recognizing his achievements in research and clinical practice. These awards celebrate his innovation in metabolic research and his pivotal role in infectious disease management. His scholarship funding reflects a legacy of excellence and a commitment to advancing medical science.

📖Training & Workshops Attended:

In his pursuit of continual growth, Dr. Rajewski has attended a series of specialized workshops on bioinformatics, advanced diagnostics, and clinical applications in infectious disease management. These workshops equip him with cutting-edge skills that he applies to his daily work, benefiting patients and enhancing the training of his medical students.

💻Contributions to Bioinformatics and Clinical Research:

A proficient bioinformatician, Dr. Rajewski integrates data science and computational tools in his research on metabolic diseases and infectious pathogens. By utilizing bioinformatics, he has been able to analyze complex datasets, leading to insights into genetic predispositions and disease progression. His ability to harness bioinformatics tools strengthens his work in both metabolic and infectious disease studies, positioning him at the cutting edge of medical research.

🎤Oral Presentations and Conferences:

As a frequent presenter at national and international conferences, Dr. Rajewski shares his research findings with the medical community. His presentations cover topics like liver disease pathogenesis, metabolic syndrome treatments, and emerging infectious diseases. He contributes actively to knowledge exchange, with his lectures serving as valuable learning resources for both peers and students.

📊Key Tasks and Responsibilities as a Researcher:

In his research role, Dr. Rajewski coordinates multi-disciplinary teams, designing studies, and conducting extensive data analyses. His responsibilities include overseeing clinical trials and ensuring the ethical integrity of research protocols. His dedication to stringent research standards has led to significant findings that improve patient care protocols and inform public health strategies.

🌠Success Factors:

Dr. Rajewski attributes his success to his commitment to continuous learning, innovation, and collaboration. His ability to bridge theoretical research with practical applications in healthcare makes his contributions exceptionally valuable. Additionally, his leadership in the clinical setting exemplifies his holistic approach to healthcare, balancing research with direct patient care.

🔍Publications & Laboratory Experience:

Dr. Rajewski’s extensive laboratory experience includes advanced diagnostics in liver diseases, where he employs innovative techniques to diagnose and manage conditions like hepatitis and liver fibrosis. His publications detail his findings on the effectiveness of new biomarkers, offering insights that enhance both diagnostics and treatment options for liver and metabolic disorders.

🌐Conclusion:

Dr. Paweł Rajewski’s career exemplifies a dedication to excellence in medicine, research, and public health. His multifaceted expertise in internal medicine, infectious diseases, and metabolic health has propelled him to the forefront of healthcare in Poland. Dr. Rajewski’s contributions are invaluable to the fields of hepatology and infectious disease, positively impacting patient care and advancing medical knowledge. Through his foundation, research, and clinical roles, he continues to shape the future of health sciences, creating a lasting legacy of compassion, knowledge, and innovation.

Top Notable Publications:

Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults